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Abstract
Background: Brahma-related gene 1 (Brg1, also known as Smarca4 and Snf2b) encodes an adenosine-5’-
triphosphate (ATP)-dependent catalytical subunit of the (switch/sucrose nonfermentable) (SWI/SNF) chromatin
remodeling complexes. SWI/SNF complexes are recruited to chromatin through multiple mechanisms, including
specific DNA-binding factors (for example, heat shock transcription factor 4 (Hsf4) and paired box gene 6 (Pax6)),
chromatin structural proteins (for example, high-mobility group A1 (HMGA1)) and/or acetylated core histones.
Previous studies have shown that a single amino acid substitution (K798R) in the Brg1 ATPase domain acts via a
dominant-negative (dn) mechanism. Genetic studies have demonstrated that Brg1 is an essential gene for early
(that is, prior implantation) mouse embryonic development. Brg1 also controls neural stem cell maintenance,
terminal differentiation of multiple cell lineages and organs including the T-cells, glial cells and limbs.
Results: To examine the roles of Brg1 in mouse lens development, a dnBrg1 transgenic construct was expressed
using the lens-specific aA-crystallin promoter in postmitotic lens fiber cells. Morphological studies revealed
abnormal lens fiber cell differentiation in transgenic lenses resulting in cataract. Electron microscopic studies
showed abnormal lens suture formation and incomplete karyolysis (that is, denucleation) of lens fiber cells. To
identify genes regulated by Brg1, RNA expression profiling was performed in embryonic day 15.5 (E15.5) wild-type
and dnBrg1 transgenic lenses. In addition, comparisons between differentially expressed genes in dnBrg1
transgenic, Pax6 heterozygous and Hsf4 homozygous lenses identified multiple genes coregulated by Brg1, Hsf4
and Pax6. DNase IIb, a key enzyme required for lens fiber cell denucleation, was found to be downregulated in
each of the Pax6, Brg1 and Hsf4 model systems. Lens-specific deletion of Brg1 using conditional gene targeting
demonstrated that Brg1 was required for lens fiber cell differentiation, for expression of DNase IIb, for lens fiber cell
denucleation and indirectly for retinal development.
Conclusions: These studies demonstrate a cell-autonomous role for Brg1 in lens fiber cell terminal differentiation
and identified DNase IIb as a potential direct target of SWI/SNF complexes. Brg1 is directly or indirectly involved in
processes that degrade lens fiber cell chromatin. The presence of nuclei and other organelles generates scattered
light incompatible with the optical requirements for the lens.
Background
Eukaryotic DNA is organized as chromatin in the
nucleus. Chromatin is a copolymer of DNA, histone and
nonhistone proteins and small noncoding RNA. During
embryonic development, specific regions of the genome
alter their chromatin organization [1]. Gene expression is
regulated at the level of the chromatin structure of indivi-
dual genes and/or loci in the context of the three-dimen-
sional organization of chromatin inside the cell nucleus.
Local chromatin structure affects multiple stages of tran-
scription, including the accessibility of sequence-specific
DNA-binding transcription factors to promoters, enhan-
cers and other genomic regulatory regions. Two major
modifications of local chromatin structure (that is,
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chromatin remodeling) include posttranslational modifi-
cations of histones and adenosine-5’-triphosphate (ATP)-
dependent alteration of nucleosomes [2].
ATP-dependent chromatin remodeling refers to
dynamic processes in which multiprotein switch/sucrose
nonfermentable (SWI/SNF), ISWI (Imitation Switch) and
nucleosome remodeling and deacetylase (NuRD) com-
plexes use nucleosomes as substrates and change positions
of individual histone octamers and/or change the topology
of DNA that is wrapped around the individual nucleosome
particles [3]. Mammalian SWI/SNF complexes, SWI/SNF-
A and SWI/SNF-B/polybromo-associated Brg1-associated
factor (PBAF), are composed of a catalytical and several
additional regulatory subunits, Brg1-associated factors
(BAFs). Brg1 (Smarca4/Snf2b) and Brahma (Brm;
Smarca2/Snf2a) are structurally similar chromatin remo-
deling ATP-dependent helicases that play distinct roles
during embryonic development [4]. Brahma-related gene
1 (Brg1, also known as Smarca4 and Snf2b) is essential for
early mammalian development as mutated embryos die
during the preimplanation phase [5]. In contrast, loss of
function of Brm leads to increased cellular proliferation in
adult mouse tissues [6]. To study Brg1 function during
organogenesis, conditional gene targeting of Brg1 was per-
formed in T-cells [7], embryonic ectoderm/keratinocytes
[8], hematopoietic/endothelial cells [9] and neural stem
cells [10]. These studies found a wide range of cell autono-
mous defects, including the control of T-cell proliferation
and survival [7], terminal differentiation of keratinocytes
[8], differentiation and apoptosis of primitive erythrocytes
[9] and neural stem maintenance and gliogenesis [10].
Mammalian SWI/SNF complexes participate in DNA dou-
ble-strand break repair as they bind to the phosphorylated
H2A histone family, member X (H2AX), histone variant,
and promote its phosphorylation [11]. Recent studies have
also established specific roles of Brg1 in DNA replication
[12]. Additional insights into the role of Brg1 in muscle
[13,14], mammary epithelium [15], smooth muscle [16,17]
and myeloid [18] differentiation have been generated
through the studies of a specific point mutation (K798R)
in the ATP-binding domain of Brg1 that act via a domi-
nant-negative (dn) mechanism [19]. In the eye, studies
using zebrafish showed that Brg1 plays specific roles in
lens and retinal development [20-22]. Eye differentiation
defects found in zebrafish mutation young (yng) were
linked to the presence of an Y390X mutation in the Brg1/
Smarca4 gene on chromosome 3 [20,21]. Nevertheless,
the existence of two Brg1-homologous genes, located on
chromosomes 3 and 6 of the duplicated zebrafish genome,
requires additional experimentation to clarify the roles of
Brg1 enzymes in vertebrate eye development.
Central to understanding chromatin remodeling in
embryonic development is to identify those genes that
are regulated by specific chromatin remodeling systems
and to elucidate the molecular mechanisms that recruit
the remodelers to specific regions of chromatin. The
molecular mechanisms of chromatin remodeling
mediated by SWI/SNF complexes were probed using a
combination of biochemical and genetic experiments.
These experiments mostly examined the function of
Brg1 as this enzyme alone can remodel nucleosomes
[23,24]. Genes regulated by SWI/SNF complexes in ver-
tebrate systems were identified using candidate gene
approaches [15,25,26] and RNA expression profiling
[14,22,27]. The SWI/SNF complexes are recruited to
DNA by at least four different mechanisms. Several line-
age-specific DNA-binding transcription factors, includ-
ing cAMP response element-binding factor (CREB),
Hsf4, microphthalmia-associated transcription factor
(Mitf), Pax6 and T-box transcription factor 2 (Tbx2),
were shown to associate with Brg1 using various in vitro
protein interaction and whole cell extract coimmuno-
precipitation assays [28-30]. Other transcription factors
associate with Brg1-associated factor (BAF) subunits,
that is, BAF60c interacts with retinoic acid receptor
(RAR) and retinoid X receptor (RXR) heterodimers [31].
Brg1 contains a 110-amino-acid-long bromodomain that
recognizes acetylated lysines in core histones [32]. Brg1
also interacts with chromosomal architectural proteins
such as high mobility group A1 (HMGA1) [33]. Thus,
CREB transcription factor, Hsf4 and Pax6 (see above)
can potentially regulate lens development via recruit-
ment of Brg1-containing SWI/SNF complexes [34,35].
Embryonic lens development is an excellent system to
study both individual cell lineage formation and terminal
differentiation. Lens lineage originates from the preplaco-
dal region that is established around the anterior neural
plate of the vertebrate embryo [36,37]. The lens placode,
a thickened surface ectoderm, is the first morphologically
distinct structure composed of lens progenitor cells.
Invagination of the lens placode generates the lens vesi-
cle, a polarized structure composed of lens precursor
cells. The posterior cells of the lens vesicle exit the cell
cycle and undergo terminal differentiation to generate
primary lens fibers. The primary lens fibers are highly
elongated cells filling the bulk of space of the original
lens vesicle. The anterior cells of the lens vesicle subse-
quently differentiate into the anterior lens epithelium
[38]. The lens grows through the entire lifespan as a
result of epithelial cell division and migration toward the
lens equator. When the epithelial cells reach the equator,
they undergo terminal differentiation as secondary lens
fibers. The hallmark of lens fiber cell differentiation is
the expression of lens-preferred genes, the crystallins
[34], and synchronized degradation of all subcellular
organelles [39]. Lens fiber cell denucleation (karyolysis) is
a final stage of this process that destroys the lens chro-
matin and/or epigenome. Aside from the active role of
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the acid DNase IIb in this process, very little is known
about molecular pathways that regulate lens fiber cell
denucleation [39].
To investigate the role of Brg1 in lens fiber cell differ-
entiation, we expressed a dn mutant of Brg1 using the
lens-specific aA-crystallin promoter in postmitotic lens
fibers. We examined lens growth and differentiation,
focusing on the potential defects in the lens fiber cell
denucleation process. Next, we identified differentially
expressed genes in this system and compared these
genes with genes regulated by Hsf4 and Pax6, two line-
age-specific DNA-binding transcription factors shown to
associate with SWI/SNF complexes through the Brg1
subunits [29,30]. The role of Brg1 during embryonic
lens development was examined by conditional Brg1
gene inactivation in mouse embryos.
Results
Expression of Brg1 in mouse embryonic eye
Previous studies using in situ hybridization in mouse
showed that Brg1 is ubiquitously expressed and accumu-
lates in differentiating cells in the nervous system, includ-
ing brain, spinal cord and retina [40]. To explain the Brg1
loss-of-function studies performed here, we first deter-
mined the endogenous expression pattern of Brg1 during
mouse eye embryonic development (embryonic days
E10.5 to E16.5) and in 3-week-old (postnatal day 21, P21)
mouse eye using immunohistochemistry as shown in Fig-
ure 1. Brg1 was detected at embryonic day 10.5 (E10.5) in
the surface ectoderm, in the invaginating lens placode, in
the periocular mesenchyme and in the anterior part of
the optic cup, the prospective neuroretina (Figure 1A).
By day E11.5, Brg1 staining was maintained in the surface
ectoderm and the periocular mesenchyme, with speckled
localization in the proliferating lens epithelial cells and in
the anterior region of the optic cup (Figure 1B). In the
differentiating lens (day E14.5), Brg1 was expressed in the
lens epithelium and in primary lens fibers (Figure 1C). In
addition, Brg1 was expressed predominantly in the sur-
face ectoderm-derived tissues and in the neural retina. At
day E16.5, Brg1 was found in the cornea, the lens, the
neural retina and the optic nerve (Figure 1D). In the
developing lens, the Brg1 proteins exhibited nuclear loca-
lization in the proliferating lens epithelium and the dif-
ferentiating lens fiber cells that still retained their nuclei
at the lens transitional zone (Figure 1E). At day P21
(Figures 1F-1I), strong Brg1 staining was detected in the
photoreceptors (P), ganglion cell layers (GCL) and the
inner nuclear layer (INL) of the retina (Figure 1G). In the
lens, Brg1 expression was restricted to the single-layered
lens epithelium and within the nuclei of fiber cells at the
transitional zone (Figure 1I). In addition, a number of
Brg1-positive cells were also visible in the corneal
epithelium (Figure 1H). These data show that Brg1 is
expressed both in lens progenitor cells and in early and
late differentiating lens fiber cells.
Expression of dominant-negative Brg1 (dnBrg1) in
transgenic lens disrupts lens fiber cell differentiation
and induces cataract formation
To address the function of Brg1 in mammalian lens devel-
opment, we generated transgenic mice in which dnBrg1,
tagged with C-terminal FLAG, was expressed using the
tissue-specific aA-crystallin promoter (Figure 2A). This
promoter fragment (-366 to + 46) drives heterologous
gene expression from day E11.5 in postmitotic lens fiber
cells [30,41,42]. The dnBrg1 contains a point mutation in
the ATP binding motif at lysine residue 798 (Figure 2A),
which is required for ATP-binding and helicase activity
[19]. This mutation generated a dysfunctional protein that
exerted dominant-negative effects versus wild-type Brg1
on transcription in yeast [19] and in cultured mammalian
cell lines [13,14,17,18,43]. Three transgenic founders (B1
to B3) were initially obtained, and they all displayed similar
lens abnormalities: the microdissected transgenic lenses
were smaller and opaque compared to the wild-type lenses
(Figure 2B). Immunofluorescence analysis via FLAG anti-
body confirmed transgene expression in differentiating
primary lens fibers cells (data not shown). The B3 hetero-
zygous transgenic founder was selected for subsequent
studies, and the wild-type littermates were used as con-
trols in each experiment.
Analysis of lens fiber cell terminal differentiation in
dnBrg1 transgenic mouse
To evaluate the impact of transgenic dnBrg1 expression
on lens development, we performed histological analyses
of wild-type and dnBrg1 eyes at different developmental
and postnatal stages (days E12.5 to P90). No changes
were found at the onset of primary lens fiber cell differ-
entiation at day E11.5 (data not shown). At day E12.5,
wild-type lens primary fiber cells almost reached the lens
epithelium in wild-type lens (Figure 3A). In contrast,
transgenic primary lens fibers exhibited delayed cell elon-
gation (Figure 3B). At day E13.5, both wild-type and
dnBrg1 primary lens fiber cells filled the lumen of the
lens vesicle (Figures 3C and 3D). However, in transgenic
lenses, the nuclei of primary lens fiber cells were located
more anteriorly compared to the wild-type lenses. In
addition, transgenic lens fiber cells showed increased
convex curvature, an indirect indication of abnormal
fiber-to-fiber cell contacts. At day E15.5, normal lenses
established the characteristic “bow” pattern of their
nuclei (Figures 3E and 3G). In transgenic lenses, a large
number of primary lens fiber cell nuclei were found scat-
tered across the lens equator, which might indicate a
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delay of lens terminal differentiation in the transgenic
embryos (compare Figures 3E and 3G with Figures 3F
and 3H).
In the postnatal dnBrg1 transgenic mice, lens abnorm-
alities became more prominent and culminated with
severe deterioration of the lens structure (Figure 4). In
wild-type mouse, an organelle-free zone (OFZ) was
established in the center of the lens, with the cortical
lens fiber cells containing degrading nuclei (Figures 4A
and 4B). In contrast, the dnBrg1 P1 lenses were smaller,
with broader transitional zones and more fiber cell
nuclei presented across the lens (Figures 4F and 4G). At
day P7, a number of dnBrg1 lens fiber cells nuclei
expanded from the transitional zone toward the center
of the lens (Figure 4H). In contrast, in the transitional
zone of the wild-type lens, fiber nuclei could hardly be
discerned, as they were gradually undergoing denuclea-
tion (Figure 4C). In day P21 lenses, cataracts were
formed in transgenic dnBrg1 lenses (Figure 4I), consis-
tent with the external evidence of lens opacification (see
Figure 2B). Finally, at day P90, the transgenic lenses
showed disrupted internal microstructure characterized
by distorted external shape and the presence of multiple
large vacuoles (compare Figures 4E and 4J).
Lens fiber cell denucleation plays a major role in these
cells’ terminal differentiation. From days E13.5 to P7,
various abnormalities associated with the position, num-
ber and morphology of nuclei are shown in Figures 3
and 4. To further address these issues, we examined
lens fiber cell nuclear degradation and formation of the
OFZ from the days E15.5 to P7 stages (Figure 5). The
OFZ was formed in the wild-type lens of day E17.5
embryos (Figures 5C and 5E). In contrast, transgenic
dnBrg1 fiber cell nuclei were retained and predomi-
nantly localized between the anterior lens epithelium
and equatorial area (Figures 5D and 5F). At postnatal
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Figure 1 Brahma-related gene 1 (Brg1) expression profile during
mouse ocular development. (A-I) Sagittal sections were
immunostained with antibody recognizing Brg1 (brown) and
counterstained lightly with hematoxylin (purple) at embryonic days
E10.5 (A), E11.5 (B), E14.5 (C) and E16.5 (D and E), as well as postnatal
day P21 (F-I). Higher-magnification areas stained with the Brg1
antibody indicated in (D) are shown in (E). (G-I) Brg1 at different
ocular regions of (F). C: cornea, Ep: cornea epithelium, GCL: ganglion
cell layer, INL: inner nuclear layer, L: lens, NR: neural retina, OC: optic
cup, ON: optic nerve, P: photoreceptors, PM: periocular mesenchyme,
SE: surface ectoderm, T: transition zone. Magnification: (A), ×460;
(B and C), ×320; (D), ×250; (E), ×400; (F), ×60; and (G-I), ×320.
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Figure 2 Generation and initial evaluation of the dnBrg1
transgenic mice. (A) Schematic of the transgenic construct. aA-
crystallin promoter fragment (-366 to + 46, Cryaa; blue arrow) was
used to express mutated Brg1 (K798R) with a C-terminal FLAG tag
(green triangle). ATPase domain (yellow) and bromodomain (blue)
are shown. (B) Two-month-old wild-type (WT) and transgenic mice.
Note the cataract formation in the transgenic mouse and in isolated
lens.
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stage P7, the transgenic lens exhibited an expanded
transitional zone at the expense of a smaller presump-
tive OFZ (compare Figures 5G and 5H).
On the basis of the lens fiber cell morphological abnorm-
alities observed in the transgenic mice, we reasoned that
the dnBrg1 expression could affect lens fiber cell ultra-
structure and contacts between individual lens fiber cells.
Scanning electron microscopy (SEM) analysis of 6-month-
old wild-type mouse lens revealed normal overlapped fiber
cell layers forming three equally long suture branches as a
“Y” pattern at the lens pole (Figure 6A), which is a charac-
teristic of mice, rats, guinea pigs, cats, dogs and cows lenses
[44]. The lens posterior pole demonstrated normal fiber
end curvature and suture plane formation. The midcortical
growth shells displayed uniform fiber cell mass and
ordered arrangement of the ball-and-socket structure. In
contrast, no typical “Y” suture pattern was found in the
dnBrg1 lens (Figure 6B). The lens pole was fractured as the
ends of most surface lens fibers failed to abut and overlap
to form the three spherical suture branches. Consequently,
the abnormal end-to-end arrangement of the lens fibers in
the growing shells disturbed the formation of a smooth
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Figure 3 Disruption of lens fiber cell differentiation in the
dnBrg1 transgenic embryos. Hematoxylin and eosin-stained lens
midsections from wild-type (A, C, E and G) and dnBrg1 (B, D, F
and H) embryos at different embryonic stages. Scale bar, 100 μm.
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Figure 4 Disrupted lens fiber cell denucleation and protein
aggregation in postnatal dominant-negative (dn) Brg1 eyes.
Histological lens midsections were obtained from wild-type (A-E)
and transgenic mice (F-J) from postnatal stages (days P1, P7, P21
and P90). Wild-type lenses gradually develop organelle-free zones
(OFZs) from the center of the lens, but dnBrg1 transgenic lens fiber
cell nuclei remain in the differentiated lens fiber cells (F and G) and
are particularly evident at the lens transitional zones (G and H).
Lens protein aggregation was evident in day P21 (I) and day P90 (J)
transgenic animals. Grossly distorted lens structure (J) was observed
in the Brg1DN ocular system at day P90. L, lens; T, lens transitional
zone.
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spherical lens surface (see Figures 6C-6F). In addition, the
uniform thickness of the lens fibers and the organized
suture pattern were absent in the transgenic lens [44]. The
uneven width of the lens fibers was found in the transgenic
mice, and the fiber cell “ball-and-socket” alignment pattern
was perturbed (compare Figures 6E and 6F).
We next used analysis of 1-μm semithin sections fol-
lowed by transmission electron microscopy (TEM) to
further characterize lens fiber cell abnormalities in the
dnBrg1 transgenic lens (Figure 7). In lenses of dnBrg1
transgenic animals, the fibers in the core of the lens
were completely disrupted and replaced by amorphous
material (Figure 7A). Lens fibers next to this amorphous
zone appeared to be structurally intact, which contained
intensely labeled granular material close to their cell
border, as well as some nuclei (Figure 7B). Nuclei were
more frequently observed in lens fibers that were
arranged peripherally to those that showed intense
staining at their cell border (Figure 7B). At the posterior
pole of the lens, fibers did not contact each other
(Figure 7B), which resulted in a fiber-free zone under-
neath the posterior lens capsule, an observation that
correlated with the findings obtained by SEM. By TEM,
nuclei were regularly observed in lens fibers close to the
bow region. The nuclei showed a homogeneous struc-
ture and usually contained one nucleolus that was seen
in cross sections (Figure 7C). The lens fibers that were
localized more closely to the core, and which showed
intense granular staining close to their cell border by
light microscopy, contained numerous electron-dense
granules with an average diameter of about 500 nm.
Nuclei which were observed more rarely than in
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Figure 5 Disruption of fiber cell nuclei degradation in
embryonic and postnatal dnBrg1 transgenic lenses. Lens
midsections from both wild-type and Brg1DN mice from embryonic
day 15. 5 (A and B), embryonic day 17.5 (C-F) and postnatal day P7
(G-H) were stained with hematoxylin and eosin. Failure of fiber cell
nuclei degradation (H, arrows) and organelle-free zone formation
was observed in the transgenic mice from embryonic stage E17.5
and persisted in postnatal stages. Scale bar, 100 μm.
WT dnBrg1
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Figure 6 Aberrant lens fiber cell organization in the dnBrg1
transgenic mouse. Absence of “Y” suture formation (compare A
and B) and ball-and-socket structure (compare C and E with D and
F) revealed by scanning electron microscopy (SEM) suggested
abnormal fiber cell differentiation in the transgenic mouse (age 3
mo). Altered fiber cell widths as well as a disturbed fiber cell
organization pattern are shown at higher magnifications (C-F). Scale
bars, 0.5 mm (A-B); 20 μm (C-D); 5 μm (E-F).
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peripheral fibers contained electron-dense granules of a
size comparable to those seen in the peripheral cyto-
plasm, as well as numerous fine electron-dense particles
that were considerably smaller (Figure 7D). Fibers of
wild-type lenses contained finely granular cytoplasm
observed by TEM (Figure 7F) and showed an overall
ordered organization by semithin light microscopy (Fig-
ure 7E). Nuclei were present only in and next to the
bow region (Figures 7E and 7F).
To evaluate the expression of two key markers of lens
fiber cell differentiation in wild-type and transgenic
lenses, we used antibodies specific to aA-crystallin and
major intrinsic protein of lens fibers (main intrinsic
polypeptide (MIP), also known as aquaporin O and
MIP26) to perform immunochemical staining. We
found reduced expression of both lens structural pro-
teins in the transgenic mice (Additional file 1). Next, to
formally exclude the possibility that transgenic lens
fibers reentered cell cycle, we performed bromodeoxyur-
idine (BrdU) incorporation assays and detected prolifer-
ating cells only in the lens epithelium (Additional file 2).
From these morphological, microscopic and immunohis-
tochemical studies, we concluded that lens-specific
expression of dnBrg1 disrupted proper fiber cell organi-
zation and suture formation, which impaired the optical
quality of transgenic lenses and contributed to progres-
sive cataract formation.
Identification of differentially expressed genes between
dnBrg1 transgenic and wild-type lenses
We next performed RNA expression profiling using
DNA microarrays to compare gene expression levels in
wild-type and dnBrg1 transgenic embryonic (day E15.5)
lenses. This time point was selected for the relative ease
of dissecting lenses from mouse embryos with still rela-
tively minor phenotypic changes (see Figure 3). Thus,
the RNA expression data reflect changes in gene regula-
tion approximately 72 hours after the onset of trans-
genic expression. Four sets of biological replicates were
used for DNA microarray hybridization with Affymetrix
Mouse Genome 430A 2.0 arrays (Affymetrix, Santa
Clara, CA, USA). The statistical and bioinformatic ana-
lyses were performed as described in Methods. Initially,
we identified 6,828 differentially expressed transcripts
between the dnBrg1 transgenic and wild-type lenses
from a total number of over 22,000 mouse genes repre-
sented on the array (Figure 8A). Among them, 3,208
were upregulated and 3,620 were downregulated tran-
scripts, respectively. As expected, the microarray data
revealed approximately fourfold upregulation of tran-
scripts encoding Brg1, and this result was independently
confirmed by quantitative real-time polymerase chain
reaction (qRT-PCR) (Figure 8B). These results suggest
that the mRNA encoding mutated and wild-type Brg1
mRNA were generated at a ratio of approximately 3:1 in
day E15.5 transgenic lenses.
Several genes implicated in lens differentiation were
found among the 6,828 differentially expressed
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Figure 7 Fine structure analysis of lens fiber cell abnormalities
in the dnBrg1 transgenic lens. Semithin sections (A, B, and E)
and transmission electron microscopy (C, D, and F) of dnBrg1
transgenic lenses (A-D) and that of wild-type littermates (E and F).
(A) In lenses of dnBrg1 transgenic animals, the fibers in the core of
the lens are completely disrupted and replaced by amorphous
material (asterisk). At the posterior pole of the lens, fibers do not
contact each other (black arrows). The boxed area is shown at
higher magnification in (B). (B) Lens fibers next to the central
amorphous zone contain intensely labeled granular material close
to their cell border, as well as some nuclei (black arrows). Nuclei are
more frequent in more peripheral lens fibers (white arrows). (C)
Nuclei (white arrow) of peripheral lens fibers show a homogeneous
structure containing nucleoli. (D) Lens fibers that are localized more
closely to the core contain numerous electron-dense granules with
an average diameter of about 500 nm. Nuclei (white arrow) contain
electron-dense granules of a size comparable to those seen in the
peripheral cytoplasm, as well as numerous fine electron-dense
particles that are considerably smaller. (E and F) Fibers of wild-type
lenses show an overall ordered organization. Note that nuclei are
only present in and next to the bow region. Scale bars, 100 μm (A
and E); 10 μm (B); 5 μm (C, D and F).
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transcripts. We selected 16 of these genes for secondary
validation using qRT-PCR (Additional files 3 and 4).
The analysis was carried out with cDNA prepared from
independent pools of day E15.5 wild-type and dnBrg1
total lens RNA preparations as described in Methods.
Internal controls (B2m, Hprt and Sdha) were included
for data normalization [45]. These results confirmed
upregulation of 12 genes (Bfsp1, Cdkn1b/p27, Dnmt3a,
Fgfr1, Gsn, Hif1a, Hod/Hop, Mab21l1, Prox1, Smarcd1,
Smarce1 and Vim) and downregulation of 3 genes (Dna-
se2b, Jag1 and Pitpnm2) in the dnBrg1 lenses (Addi-
tional file 3). Expression of Six3 showed no change on
the arrays and minor downregulation by qRT-PCR
(Additional file 3). In addition, we examined expression
of Brm (Smarca2) in this system to address potential
increase or decrease of expression of this ATPase [4].
We found a moderate upregulation of Smarca2 tran-
scripts (1.92-fold for array data and 1.50-fold for qPCR
data). Upregulation of Smarcd1 and Smarce1, two genes
encoding noncatalytic subunits of SWI/SNF complexes,
was also validated (Additional file 3). From these data,
we concluded that approximately one third of the lens
transcriptome was directly or indirectly affected by the
transgenic overexpression of dnBrg1 with comparable
numbers of up- and downregulated transcripts.
To further explore the dnBrg1-affected transcriptome
remodeling, Gene Set Enrichment Analysis (GSEA) [46]
was employed to identify significantly enriched molecu-
lar signatures disrupted in this transgenic model on the
basis of normalized enrichment score (NES) ranking.
Next, we assigned those groups into three categories:
chromatin, lens biology and neuronal function, as
shown in Additional file 5. The two most enriched sig-
natures in the downregulated gene population (Figure 9)
contained genes classified as “nervous system develop-
ment” and “neurodegenerative diseases” with 37%
(111 of 300) and 42% (14 of 33) respective signature
enrichment, suggestive of disruption of Brg1-dependent
programs associated with neural development as
reported previously [10].
To identify individual genes regulated by Brg1 that
explain lens fiber cell differentiation defects, we looked
for genes that were deregulated in two functionally
related systems: Pax6 and Hsf4. Pax6 regulates multiple
stages of lens development [47,48]. In contrast, Hsf4 reg-
ulates lens fiber cell terminal differentiation [49]. As Pax6
[30] and Hsf4 [29] have been implicated as specific DNA-
binding transcription factors that recruit Brg1 (and by
inference SWI/SNF complexes) to specific regions of the
genome, we further compared transcripts regulated in
dnBrg1 transgenic lenses with the Pax6-heterozygous
[45] and Hsf4-null lenses (see Methods). We found a
total of 178 deregulated transcripts in both dnBrg1 and
Pax6 heterozygous lenses (Figure 10A). In Hsf4-null
lenses, we identified 1,428 differentially expressed tran-
scripts. Among those, 559 transcripts were differentially
expressed in both dnBrg1-transgenic and Hsf4-null lens
models. Twenty-two differentially expressed genes were
found in all three experiments, and they are listed in
Figure 10B. This group included Dnase2b, a gene encod-
ing acid nuclease DNase IIb [39]. This enzyme is critical
for lens fiber cell denucleation [39,50] and its downregu-
lation in dnBrg1 transgenic lenses (Additional file 3) is
consistent with lens fiber cell denucleation defects
described above (see Figures 4 and 5).
Using the Database for Annotation, Visualization and
Integrated Discovery (DAVID), we further classified those
178 genes that were commonly deregulated in both Pax6
heterozygous and dnBrg1 transgenic lenses (Figure 10A).
A total of 130 genes (73%) were classified using the
DAVID tool. Among these, there were 63 individual genes
with partially redundant presence in multiple Gene Ontol-
ogy (GO) categories. For example, the Dnase2b gene was
found in GO Biological Process category “DNA metabolic
process,” GOMolecular Function category “nuclease activ-
ity,” GO Cellular Compartment “vacuole” and Kyoto
Encyclopedia of Genes and Genomes (KEGG) Pathway
“lysozome” (Additional file 6). Among the top-ranking GO
categories we identified were GO Molecular Function
“nucleotide binding” (n = 20, P = 0.005), “DNA metabolic
process” (n = 6, P = 0.043) and “DNA replication” (n = 4,
P = 0.032). These results are in agreement with Brg1’s
serving as a global regulator of chromatin and chromatin-
associated processes including DNA repair [11] and DNA
replication [12].
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Figure 8 Gene expression profiling in wild-type and dnBrg1
lenses (day E15.5). (A) Four biological triplicates (R1 through R4) of
mouse lenses were analyzed by Affymetrix GeneChip arrays to identify
a set of 6,828 individual genes significantly modulated between wild-
type (WT) and Brg1DN lenses. Statistical filtering of array data was
performed as described in Methods. (B) Differential expression of
Smarca4 (Brg1) gene determined by the arrays and quantitative reverse
transcriptase polymerase chain reaction (qRT-PCR).
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Targeted deletion of Brg1 causes multiple eye
developmental abnormalities
To further examine the role of Brg1 in the regulation of
lens morphogenesis, we performed conditional knockout
(cKO) of Brg1 by crossing Brg1flox/flox [7] mice with Le-
Cre-transgenic mice [47]. The Le-Cre mouse is used to
inactivate genes in the embryonic head surface ectoderm
cells that give rise to the lens [47,51,52]. The onset of
Le-cre activity was previously reported to commence
around day E9.0 [47], corresponding with the activity of
the Pax6 ectodermal enhancer (EE) [53]. The Brg1flox/flox
mice and the Le-Cre mice did not show any phenotypic
differences in comparison with the wild type (Figure 11
and data not shown). Therefore, we used the Brg1flox/flox
mice as controls in our experiments. Following this Cre-
lox-mediated deletion strategy, Brg1flox/flox, Le-Cre and
Brg1flox/+ Le-Cre conditional knockout mice were
obtained in the expected Mendelian ratios. The Brg1flox/
A
C
14 genes
111 genes
WT  dnBrg1B
D
Figure 9 Gene Set Enrichment Analysis (GSEA) analysis of two significantly enriched classes of genes: nervous system development
and neurodegenerative diseases. (A) Enrichment plot for a category nervous system development that includes 300 genes. (B) Normogram
for 111 core-enriched genes classified in nervous system development. (C) Enrichment plot for a category of neurodegenerative diseases that
includes 34 genes. (D) Normogram for 14 core enriched genes classified in neurodegenerative diseases. Individual genes are listed in Additional
file 5. Increased expression (red); decreased expression (blue).
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+ Le-Cre mice appeared normal in terms of lens gross
morphology (data not shown). These findings suggest
that one allele of Brg1 was sufficient for normal eye
development. In contrast, the majority of Brg1flox/flox Le-
Cre mice (referred to herein as Brg1 cKO mutants)
showed severe microphthalmia (that is, reduced size of
the eye) as visually identified after birth (Additional file
7). Analysis of 47 Brg1 cKO embryos revealed different
severity of ocular abnormalities in lens, retina and other
tissues in 70% of the conditional knockout mutants
(Table 1). In addition, in 2 of 47 embryos, aphakia (that
is, absence of lens) was found. Analysis of the efficiency
of the conditional knockouts revealed that in many
embryos, deletions of both Brg1 alleles were not com-
plete (Additional file 8). These results suggest that con-
ditional inactivation of Brg1 in the surface ectoderm
triggers a cascade of ocular developmental abnormalities
in both the anterior and posterior eye segments.
Morphological and histological analysis of ocular defects
in Brg1 mutants in embryonic and postnatal eyes is
shown in Figures 11 and 12, respectively. At day E13.5,
the Brg1 mutant lenses were reduced in size compared
to the controls (Figures 11A, 11B and 11C). A clear
discrimination between the lens epithelium and the lens
fiber cells is also missing. In some cases, no anterior
and posterior chambers were generated as the lens
epithelial layer remained attached to the surface ecto-
derm, and the mesenchymal cells between posterior lens
and the optic nerve failed to degrade (Figures 11B and
11C). Reduced lens growth and abnormal lens fiber cell
differentiation were also found at day E15.5 (Figures 11E
and 11F). In the Brg1 cKO embryos, the neural retina
was much thicker at both day E13.5 (Figures 11B and
11C) and day E15.5 (Figures 11E and 11F). In addition,
abundant mesenchymal cells were presented in the vitr-
eous region between the posterior of the lens and the
neuroretina (Figures 11E and 11F). At day E15.5, the
mutant lens fiber cells failed to elongate properly and
vacuoles could be seen across the lens microstructure
(Figures 11E and 11F). In the postnatal Brg1 mutants
(P1 and P7 stages), reduced lens size and other abnorm-
alities, including retinal misfolding, persisted (Figures
12B, 12C, 12E, 12F, and 12H). The most severe defect,
aphakia (Figure 12I), was accompanied by an aberrant
infolding of the retina. In some animals, the anterior
segment abnormalities included failures in corneal
A B
Figure 10 Identification of lenses commonly regulated in dnBrg1, Hsf4-/- and Pax6+/-. (A) Venn diagram showing number of genes and/or
transcripts regulated in dnBrg1, Hsf4-/- and Pax6+/- lenses. (B) A list of 22 genes regulated in all three systems. The genes were analyzed using
the unsupervised hierarchical clustering described in Methods. Gene Expression Omnibus database accession numbers for dnBrg1, heat shock
transcription factor 4 (Hsf4) and paired box gene 6 (Pax6) data are GSE22322, GSE22362 and GSE13244, respectively.
Table 1 A summary of gross morphology of the lens-specific Brg1 conditional knockout mice
Total number of embryos No obvious phenotype Abnormal eye development Aphakia
Brg1flox/+ ; Le-Cre 29 29 1 0
Brg1flox/flox; Le-Cre 47 14 31 2
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differentiation, formation of the anterior chamber and
cornea-eyelid separation (Figures 12B and 12C). In
adults, the mutant eyelids were often closed (Additional
file 7B). The conditional inactivation of Brg1 in the pre-
sumptive lens ectoderm shows that this enzyme is cell-
autonomously required for lens fiber cell differentiation,
indirectly for normal retinal and directly and/or indir-
ectly for anterior segment development.
Analysis of lens fiber cell denucleation in Brg1
mutants revealed retention of nuclei as well as abnormal
shape of the lens fiber cells (Figure 13). Thus, in both
dnBrg1 transgenic and in Brg1 cKO lenses, lens fiber
cell karyolysis was disrupted. In addition, we found per-
turbed expression patterns of aA- and g-crystallin pro-
teins in Brg1 mutants (Additional file 9). Expression of
Pax6 was detected in the lens epithelium of the Brg1
mutated lens (Additional file 9). To gain further insight
into both models of Brg1 function, we performed tran-
scriptome analysis in Brg1 mutants using whole eyeballs
with three sets of biological replicates and the Affyme-
trix Mouse Genome 430A 2.0 arrays (Affymetrix, Santa
Clara, CA, USA) as described in Methods. The initial
analysis revealed disrupted expression of 2,196 genes,
with 1,115 upregulated and 1,081 downregulated genes.
Interestingly, only a minor fraction (230) of modulated
genes (constituting 3.5% of dnBrg1- and 10.5% of Brg1
cKO-deregulated genes) showed similar behavior in
these two loss-of-function model systems (Figure 14).
These 230 genes are listed in Additional file 10. Never-
theless, expression of Dnase2b was reduced in both of
these systems (Additional files 3 and 10). Collectively,
our molecular profiling data establish specific roles of
Brg1 in mouse embryonic lens fiber cell differentiation
and their denucleation.
Discussion
Using a combination of two complementary genetic
approaches, the present studies demonstrate that Brg1 is
required for mouse lens fiber cell differentiation. Lens-
specific expression of the dnBrg1 perturbed lens fiber
cell differentiation process at multiple levels and
resulted in cataract formation. In these abnormal lens
fibers, nuclei were not degraded, suggesting that Brg1
participates in normal lens fiber cell karyolysis. The
advantage of this system is that function of Brg1 was
disrupted only in postmitotic lens fiber cells; however,
this system is unlikely to produce complete inactivation
of Brg1 biological activity [52]. To address this problem,
conditional inactivation of Brg1 using a MLR39 Cre
line, active only in differentiating lens fibers, would be
required [54]. In parallel, conditional inactivation of
Brg1 in the surface ectoderm resulted in a range of lens
and/or eye developmental abnormalities, including the
retention of nuclei in lens fiber cells. Incomplete dele-
tion of floxed Brg1 alleles by Le-cre followed by clonal
selection of viable cells and/or prolonged stability of
Brg1 proteins in lens cells precludes any definitive con-
clusions about the potential role of Brg1 in lens lineage
formation and lens placode invagination. In the majority
of mutants, lens vesicles were formed and differentiation
of primary lens fibers was compromised. Absence of
lens in the mutated eye was accompanied by an aberrant
infolding of the retina. Similar defects were found in
Pax6 embryos conditionally inactivated in the surface
ectoderm [47]. Collectively, the present studies reveal an
essential, novel role of Brg1 in lens fiber differentiation
and denucleation. In addition, secondary defects in ret-
inal formation suggest that Brg1 can play cell nonauto-
nomous roles in retinal development that originate from
aberrant lens morphogenesis as described elsewhere
[47,52,55-58].
Although the use of two loss-of-function approaches to
study the Brg1 function in lens development generated
comparable results at the morphological and cellular
levels, molecular studies using RNA expression profiling
identified only a small number of commonly regulated
genes (Figure 14). There are at least three factors that
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Figure 11 Early deletion of Brg1 compromise ocular
morphogenesis in the conditional knockout (cKO) mutant
embryos. Lens midsections were obtained from Brg1flox/flox and
Brg1flox/flox; Le-Cre (mutant) mice from embryonic day 13.5 (A-C) and
embryonic day 15.5 (D-F). The examined Brg1 mutant embryos still
underwent lens induction but revealed disrupted lens specification
as well as an abnormal neural retina during embryonic
development. Scale bar, 100 μm.
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could contribute to these findings. First, loss of function
of Brg1 from day E9.0, that is, prior to the morphological
formation of lens pit and/or vesicle, should impair lens
development more severely compared to the transgenic
dnBrg1 system with later onset expression (from day
~ E11.5) in postmitotic lens fibers. Second, we could not
isolate mutated lenses from comparable, that is, E15.5-
day-old, embryos because of their structural fragility.
Instead, we had to dissect eyeballs including mutated
lenses and other affected tissues, and this tissue heteroge-
neity was reflected in the eyeball transcriptome. Third,
the variability of the Brg1 cKO phenotypes (Table 1 and
Figure 12) makes it difficult to microdissect lenses, even
under ideal conditions, with abnormalities comparable to
the dnBrg1 transgenic lenses.
Previous studies of Brg1 function in other cells and
tissues established Brg1 as a specific regulator of cell
proliferation, differentiation and survival [7-9,11,12].
The present studies in lens suggest that Brg1 plays a
major role in lens fiber cell differentiation. Though
Brg1 is highly expressed in the surface ectoderm that
gives rise to the lens placode (Figures 1A and 1B),
Brg1’s role in the formation of lens lineage remains to
be determined through detailed analysis of early stage
(days E9-E10) embryos. Expression of Brg1 is reduced
in differentiating primary and secondary lens fibers.
Brg1’s role in lens fiber cell differentiation is supported
by ectopic expression of the dnBrg1 transgene in lens
and by conditional inactivation of Brg1 in the pre-
sumptive lens ectoderm. Three transgenic mouse lines
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Figure 12 Lens-specific Brg1 targeting gives rise to a variety of ocular deficiencies. The cKO mutants were compared with Brg1flox/flox
littermates at postnatal day 1 (A-C) and postnatal day 7 (D-I). The mutant mice displayed ocular defects with various severities, including failure
of cornea-eyelid separation (black arrows in B and C) or iris separation (E, I and H), aberrant lens and retina (B, C, E, F, and H) and even an
absence of lens structure (I). Scale bar, 100 μm.
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were established and generated similar lens-specific
differentiation defects. Although the lens-specific
knockout resulted in variable eye defects, in the major-
ity of embryos, we detected rudimentary lens forma-
tion. This variability could originate from incomplete
deletion of both Brg1 alleles, compensation via Brm/
Smarca2 and/or via other mechanisms such as pro-
longed stability of the Brg1 proteins. Upregulation of
Brm/Smarca2 was indeed found in the dnBrg1-trans-
genic model. A large number of transgenic lens studies
utilizing the aA-crystallin promoter induced cell cycle
reentry and/or apoptosis in the lens fiber cell compart-
ment [41,42,59-62]. In the present study, no evidence
for apoptosis (data not shown) and cell cycle reentry
(see Additional file 2) in postmitotic dnBrg1 transgenic
lens fibers was found.
Earlier studies identified aA- and aB-crystallins
(among ~ 80 other genes) upregulated in the human
adrenal carcinoma cell line SW-13, deficient in both
Brg1 and Brm expression, in which Brg1 was reintro-
duced [27,33]. Here we show reduced expression and
accumulation of aA-crystallin in dnBrg1-transgenic and
Brg1-cKO lenses that is consistent with our earlier find-
ings that abundant quantities of Brg1 are present within
a 16-kb region of lens-specific chromatin of the mouse
Cryaa locus [30]. On the basis of the data shown here
and in our earlier studies [30], we conclude that aA-
crystallin gene and/or locus is regulated directly by at
least three DNA-binding transcription factors, Pax6, c-
Maf and CREB, and by chromatin remodeling enzyme
Brg1. We propose that Brg1, and, by inference, SWI/
SNF complexes, are recruited to the Cryaa locus by
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Figure 13 Loss of function of Brg1 abrogates lens fiber cell denucleation. Lens midsections were collected from both wild-type mice and
littermates with lens-specific gene targeting of Brg1 from postnatal day 1 (A-C) and postnatal day 7 (D-I) for hematoxylin and eosin staining.
OFZ, organelle-free zone. Scale bar, 100 μm.
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Pax6 and possibly by other mechanisms, including the
recognition of acetylated lysine residues by Brg1
bromodomain.
To identify genes downstream of Brg1 in lens, we per-
formed RNA expression profiling studies in day E15.5
dnBrg1 transgenic lenses followed by comparative ana-
lyses of differentially expressed genes in Pax6
heterozygous and Hsf4 homozygous lenses. We reasoned
that if lens lineage-specific DNA-binding transcription
factors Pax6 and Hsf4 serve in vivo as recruiters of SWI/
SNF complexes to specific regions of chromatin, we
could find commonly regulated genes in these three
model systems. Among those 6,828 transcripts regulated
in dnBrg1 transgenic lenses, 715 (~ 10.5%) transcripts
were also regulated in Pax6+/- and Hsf4-/- mutated lenses.
Within the 559 differentially expressed genes in Pax6+/-
lenses, 178 (~ 32%) transcripts were shared between
these two systems. Similarly, within the 1,428 differen-
tially expressed genes in Hsf4-/- mutated lenses, 559 (~
39%) transcripts were commonly deregulated. Finally, 22
genes, including lens-preferred acid DNase IIb endonu-
clease, were found to be dysregulated in all three mutated
lenses. These results suggest that Brg1, Hsf4 and Pax6
exert their function through commonly regulated genes.
In addition, the use of the DAVID and GSEA analysis
tools for interpretation of genomewide expression pro-
files identified several functionally related groups of
genes suggesting the presence of specific Brg1-dependent
coregulated biological processes. Additional molecular
studies using chromatin immunoprecipitation (ChIP)
sequencing (ChIP-seq) and related methods are required
to demonstrate co-localization of Brg1, Hsf4 and Pax6
proteins in lens chromatin at their target genes.
The most obvious defects in dnBrg1 transgenic lens
fiber cell differentiation included the failure of lens fiber
cells to degrade their nuclei, abnormal curvature and
cell-to-cell contacts of lens fiber cells, and suture forma-
tions. All of these processes likely contributed to lens
opacities found in postnatal transgenic lenses. The most
interesting aspect of abnormal lens fibers was retention
of their nuclei. These findings add a novel role for Brg1
to control denucleation and/or karyolysis as an important
process of terminal differentiation. Downregulation of
Dnase2b transcripts in dnBrg1 transgenic lenses as well
as in conditionally deleted Brg1 lens can explain, at least
partially, this phenotype. In wild-type lenses, DNase IIb
reaches its peak activity at day E17.5 [63], and this is fol-
lowed by the establishment of an OFZ. In both the
dnBrg1-transgenic and mutated Brg1 lenses, formation of
an OFZ was not found (Figures 4 and 13). Initial analysis
of the Dnase2b promoter and its surrounding regions
identified multiple putative Pax6- and Hsf4-binding sites
(Figure 15A), suggesting that these two transcription fac-
tors regulate lens-preferred expression of this enzyme via
recruitment of SWI/SNF complexes. In addition to
DNase IIb, the present studies suggest a large number of
differentially expressed genes that belong to GO Biologi-
cal Process categories: DNA repair, establishment and/or
maintenance of chromatin architecture, response to
DNA damage stimulus and chromatin modification (see
Additional file 11). Given the recent link between
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Figure 14 Identification of commonly regulated genes in
dnBrg1 lenses and Brg1 cKO eyes. (A) Venn diagram showing
numbers of upregulated genes and/or transcripts found in dnBrg1
and Brg1 cKO models. (B) Venn diagram showing numbers of
downregulated genes and/or transcripts found in dnBrg1 and Brg1
cKO models. The genes and/or transcripts included in this analysis
(6,533 in dnBrg1, and 2,196 in Brg1 cKO, respectively) were selected
by two parameters: Pavlidis template matching (PTM), P < 0.05, and
fold change > 1.5 as described in Methods [68].
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Figure 15 Summary of two complementary models illustrating Brg1’s role during lens fiber cell differentiation. (A) A schematic of the
Dnase2b locus including its evolutionarily conserved promoter region (-205 to + 180). Multiple Pax6- and Hsf4-binding sites were identified in
the DNase2b promoter and 3’-downstream evolutionary conserved region. Hsf4 and Pax6 recruit (switch/sucrose nonfermentable) (SWI/SNF)
complexes as described elsewhere [29,30]. (B) A schematic of a DNA double-strand break (DSB) accompanied by insertions of H2A histone
family, member X (H2AX) histone variant (nucleosomes shown in purple). Both SWI/SNF (including Brg1) and DNA repair (including Nbs1)
complexes are then recruited to the chromatin. Both complexes are thought to regulate chromatin structure prior to and during lens fiber cell
denucleation. In mouse, Nbs1-deficient lenses show incomplete denucleation of lens fiber cells [71].
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ubiquitin metabolism and lens fiber cell denucleation
[64], we also identified differentially expressed genes that
belong to the GO categories ubiquitin cycle, proteasome
and ubiquitin-mediated proteolysis. These genes are
excellent candidates for mechanistic studies of lens fiber
cell denucleation. Finally, it is also possible that SWI/
SNF complexes containing Brg1 participate in the pro-
cess of lens fiber denucleation independently through
controlling local chromatin structure in those regions
that exhibit initial DNA damage. This is supported by
our recent study that revealed formation of DNA double-
stranded breaks repair through visualization of phos-
phorylated H2AX in the lens fiber cell compartment [41].
Both models of Brg1’s role (and by inference the role of
SWI/SNF complexes) in lens fiber cell denucleation (Fig-
ure 15) are not mutually exclusive. Ongoing experiments
are aimed to test these hypotheses.
Conclusions
Our results demonstrate that lens fiber cell terminal dif-
ferentiation, including their denucleation (karyolysis),
requires the ATP-dependent chromatin remodeling
enzyme Brg1. Our data suggest that Brg1, together with
two lens lineage transcription factors, Pax6 and Hsf4, is
required for the transcriptional regulation of DNase IIb,
the key enzyme for lens fiber cell denucleation. In addi-
tion, the present data are consistent with our earlier
findings suggesting that Brg1 regulates directly the
expression of the aA-crystallin gene, the key structural
protein of the mammalian lens. These results provide
new molecular insights into the process of lens fiber
terminal differentiation and open new research avenues
to probe chromatin structure prior to and during lens
fiber cell denucleation.
Methods
Antibodies
The primary antibodies used were Brg1, aA-crystallin, g-
crystallin, Pax6, MIP/MIP26/aquaporin 0 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and Flag M2
(Sigma-Aldrich, St. Louis, MO, USA). The secondary
antibodies used were Alexa 568 goat anti-rabbit (Mole-
cular Probes, Eugene, OR, USA) and biotin-conjugated
secondary anti-rabbit (EO466; Dako, Carpintera, CA,
USA).
Generation of transgenic dnBrg1 mice
The plasmid pACP3 [59] was modified to insert EcoRV
and MluI restriction sites into both 5’- and 3’-NotI sites
that flank the aA-crystallin promoter/polylinker/simian
virus 40 (SV40)/polyA sequences. A Brg1 cDNA con-
taining the K798R mutation was cloned as a 5.2-kb
ClaI-SpeI fragment obtained from pBluescript KS
(+)-FLBrg1Mut [23] to generate pCryaa/dnBrg1 (see
Figure 2A). A 7.2-kb EcoRV fragment was released from
this plasmid and used to generate transgenic mice by
injection into FVB/N fertilized oocytes. Transgene inte-
gration was confirmed by genomic PCR using tail DNA
with the following primers: 5’-ATGGCTCCAGGG-
GAAGG-3’ and 5’-CATTCCTTTCATCTGGTTG-3’.
The cycling parameters were 94°C for 30 s, 55°C for 45
s and 72°C for 70 s for 35 cycles.
Conditional inactivation of Brg1 in the presumptive lens
ectoderm
Brg1flox/flox mice [7] were mated with Le-Cre-transgenic
mice [47], and the progeny were crossed to generate lit-
ters containing homozygous floxed alleles and heterozy-
gous for the Cre transgene. Mice genotyping was
performed as described previously in the literature
[7,47]. Animal husbandry and experiments were con-
ducted in accordance with the approved protocol of the
Albert Einstein College of Medicine Animal Institute
Committee and the Association for Research in Vision
and Ophthalmology Statement for the use of animals in
ophthalmic and vision research. Noon of the day the
vaginal plug was observed was considered to be day
E0.5 of embryogenesis.
Histological analysis
Animals were killed by CO2, and either the embryos
were dissected from pregnant females or whole eyeballs
were removed from postnatal animals. Tissues were
then fixed in 10% neutral buffered paraformaldehyde
overnight at 4°C, processed and embedded in paraffin.
Serial sections were cut in 5-μm thickness through the
midsection of the lens and stained with hematoxylin
and eosin or used for subsequent experiments. Immuno-
histochemistry was performed as described previously
[65] with the 3,3’-diaminobenzidine (DAB) kit (Vector
Laboratories, Burlingame, CA, USA). Indirect immuno-
histological staining was conducted following standard
procedures. Briefly, sections were washed twice in Tris-
buffered saline (TBS) and blocked for 30 min with
Image-iT™ FX signal enhancer (Molecular Probes). Then
sections were washed twice in TBS before undergoing
primary antibody incubation in 1% Bovine Albumin
Fraction Solution (Invitrogen, Grand Island, NY, USA)
and 0.1% (vol/vol) Triton X in TBS overnight at 4°C in
a humidified chamber. After being washed twice in PBS,
sections were incubated with the secondary antibody for
1 h at room temperature. Sections were then washed
three times with PBS and mounted with fluorescence
preserve mounting medium (Vector Laboratories). Pri-
mary antibodies were diluted (vol/vol) as follows: Brg1
(1:200), aA-crystallin (1:1,000), g-crystallin (1:1,000),
Flag (1:150), MIP26 (1:200) and Pax6 (1:400). Secondary
antibodies were diluted as follows: Alexa 568 goat
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antirabbit (1:500) and biotin-conjugated secondary anti-
rabbit (1:400). For immunofluorescence staining, pri-
mary antibodies were diluted in blocking solution and
nuclei were stained with 4’,6-diamidino-2-phenylindole
(DAPI). Images were obtained with a Zeiss Axioskop II
light microscope or a Leica MZ FLIII fluorescence
stereomicroscope (Heerbrugg, Switzerland).
Scanning and transmission electron microscopy
Three-month-old mouse lenses from wild-type and
dnBrg1 animals were fixed overnight at room tempera-
ture in 0.08 M sodium cacodylate, 1.25% glutaraldehyde
and 1% paraformaldehyde (pH 7.4). After fixation, the
lens capsule and several of the outermost layers of the
fiber cells were peeled off to show the fiber pattern.
Then the lens samples were dehydrated through a
graded series of ethanol and processed by critical point
dry (CPD) using liquid carbon dioxide in a Tousimis
Samdri 795 Critical Point Drier (Rockville, MD, USA).
Subsequently, lens samples were transferred to a filter
paper, placed in vacuum desiccators, mounted on a stub
and sputter-coated for 2 min with gold-palladium in
Denton Vacuum Desk-2 Sputter Coater (Cherry Hill,
NJ, USA). Specimens were examined using a JEOL
JSM6400 Scanning Electron Microscope (Peabody, MA,
USA) with an accelerating voltage of 10 kV.
For transmission electron microscopy, eyes from 3-
month-old mice were fixed for several hours in a 2%
paraformaldehyde/2.5% glutaraldehyde solution. While
in fixative, the posterior hemispheres of eyeballs were
pierced with a fine needle. After being rinsed in 0.1 M
cacodylate buffer, eyeballs were postfixed in a mixture
of 1% OsO4 and 0.8% potassium ferrocyanide in 0.1 M
cacodylate buffer for 2 h at 4°C. Specimens were then
dehydrated in a graded series of ethanol and embedded
in Epon (Serva, Heidelberg, Germany). Semithin sections
(1 μm) were collected on uncoated glass slides and
stained with methylene blue/azure II [66] for light
microscopy. Ultrathin sections were mounted on
uncoated copper grids, stained with uranyl acetate and
lead citrate and examined on a Zeiss Libra electron
microscope.
Oligonucleotide microarrays and mRNA expression
profiling
Lenses were isolated from day E15.5 transgenic and
wild-type embryos and stored in RNA Later (Ambion,
Woodlands, TX, USA). Newborn wild-type and Hsf4-/-
lenses were described previously [49]. Whole eyeballs
were isolated from newborn wild-type and conditional
Brg1 knockouts as microdissected lenses were difficult
to obtain because of their mechanical fragility. RNA iso-
lations were performed using the RNeasy MiniElute Kit
and RNase-Free DNase set (Qiagen, Valencia, CA,
USA). RNA quality was assessed using the Agilent 2100
Bioanalyzer with the Nano LabChip Kit (Agilent Tech-
nologies, Palo Alto, CA, USA) following the manufac-
turer’s instructions. Replicate sets of RNA from distinct
day E15.5 dnBrg1 embryonic lenses (n = 4) and indivi-
dual newborn eyeballs (n = 3) and corresponding num-
bers of stage-matched wild-type littermates were
prepared for microarray analyses. cDNA synthesis and
amplifications were performed with the Ovation™ RNA
Amplification System V2 (Nugen, San Carlos, CA, USA)
using 50 ng of total RNA per sample. Amplified cDNA
were cleaned and purified with the DNA clean and Con-
centrator™-25 kit (Zymo Research, Orange, CA, USA).
Fragmentation and labeling were performed using the
FL Ovation™ cDNA Biotin Module V2 (Nugen) accord-
ing to the manufacturer’s instructions. The samples
were subsequently hybridized on Mouse Genome 430A
2.0 arrays (Affymetrix, Santa Clara, CA, USA) following
the manufacturer’s specification.
Bioinformatic tools and statistical filtering of RNA
microarray results
Differentially regulated genes and/or mRNA between
dnBrg1 and wild-type lenses were identified using biolo-
gical quadruplicate sets (n = 4) of robust multichip aver-
age (RMA)-normalized Affymetrix CEL files [67] by a
conjunction of Student’s t-test (P < 0.05) and signifi-
cance analysis of microarrays (SAM; false discovery rate
FDR set to < 1%), using the TIGR Multiexperiment
Viewer of the TM4 suite (Dana-Farber Cancer Institute,
Boston, MA, USA) [68]. A similar strategy was used to
identify differentially regulated genes and/or mRNA
between Hsf4-null and wild-type lens (biological tripli-
cates, RMA normalization, conjunction of t-test; P <
0.05 and SAM FDR < 5%). Primary data from this study
were deposited in the National Center for Biotechnology
Information (NCBI) Gene Expression Omnibus database
under accession numbers GSE22322 (the dnBrg1 part),
GSE22362 (the Hsf4 part) and GSE25168 (the Brg1 cKO
part). The R-based extension to GeneSpring GS7 (Agi-
lent Technologies, Santa Clara, CA, USA) was used to
create a boxplot representation of 6,828 Brg1 target
genes in Figure 8 to generate a five-number summary
including the smallest observation, lower quartile, med-
ian, upper quartile, largest observation and indications
of outlier observations. The GO and KEGG pathway
functional annotations were performed using the
National Institutes of Health web-based tool DAVID
(Database for Annotation, Visualization and Integrated
Discovery) [69]. GSEA (http://www.broad.mit.edu/gsea/)
was additionally used to identify significantly enriched
pathways disrupted in dnBrg1-transgenic lenses [46].
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qRT-PCR
Relative expression levels of 16 genes were verified by
qRT-PCR. Total RNA from biological triplicates of
transgenic and wild-type littermate lenses were isolated
using RNeasy MiniElute Kit and RNase-Free DNase set
(Qiagen, Valencia, CA, USA). Subsequently, cDNA was
synthesized with Random Haxamer primers (Invitrogen)
and Superscript TM III Reverse Transcriptase (Invitro-
gen) following the manufacturers’ instruction. cDNA
was diluted 10 times, and qRT-PCR was performed
using the Applied Biosystems (ABI, Foster City, CA,
USA) 7900HT fast Real-Time PCR system with Power
SYBR Green PCR master mix (ABI). Specific primers for
qRT-PCR are listed in Additional file 12. Primers were
designed across neighboring introns using NCBI Pri-
mer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-
blast/index.cgi). Transcripts encoding b2 microglobulin
(B2M), succinate dehydrogenase complex subunit A
(SDHA), and hypoxanthine-guanine phosphoribosyl-
transferase (HPRT) genes were used for normalization
of expression levels of both transgenic and wild-type
results as described previously [45,70].
Additional material
Additional file 1: Reduced expression of aA-crystallin and main
intrinsic polypeptide (MIP), also known as aquaporin O and MIP26,
in dominant-negative (dn) Brahma-related gene 1 (Brg1) (dnBrg1)
transgenic lens. Immunohistochemical staining using antibodies against
aA-crystallin and MIP26 (aquaporin 0) revealed reduced expression of
these two lens structural proteins in the dnBrg1 transgenic adult lenses.
Note an evident lack of staining of both of the two proteins from the
center of the lens, where the cataract is mainly initiated.
Additional file 2: Cell proliferation in the dnBrg1 lenses.
Immunohistochemical staining using antibodies against
bromodeoxyuridine (BrdU) revealed no significant differences in lens
epithelial cell proliferation in the embryonic day E15.5 lenses from wild-
type (A and C) and dnBrg1 littermates (B and D). Higher magnification
of the anterior lenses of embryonic day E15.5 wild type (C) and dnBrg1
(D) are shown. Scale bar, 100 μm.
Additional file 3: Verification of microarray results by quantitative
real-time polymerase chain reaction (qRT-PCR). Relative expression
levels of Bfsp, Cdkn1b, Dnase2b, Dnmt3a, Fgfr1, Gsn, Hif1a, Hod, Jag1,
Mab21l1, Pitpnm2, Prox1, Six3, Smarcd1, Smarce1 and Vim transcripts in
wild-type (WT; shown in black) and dnBrg1 (shown in white) lenses were
determined using qRT-PCR as described in Methods. b2 microglobulin
(B2m), hypoxanthine-guanine phosphoribosyltransferase (Hprt) and
succinate dehydrogenase complex subunit A (Sdha) transcripts were
tested as internal references, and all were found unchanged between
the wild-type and dnBrg1 lenses. The data are expressed relative to the
unchanged expression level of B2m transcripts.
Additional file 4: A summary of the selected genes for qRT-PCR
verification as potential candidate targets of Brg1.
Additional file 5: Classification of significant genes into three
categories: “Chromatin,” “Lens Biology” and “Neuronal Function”
following Gene Set Enrichment Analysis (GSEA). Upregulated
(downregulated) genes are shown in red (blue), respectively. Curated
gene sets, C2; GO gene sets, C5; Molecular Signature Database Class,
MSigDB Class; normalized enrichment score, NES.
Additional file 6: Functional grouping of 178 genes that were
commonly deregulated in both Pax6 heterozygous and dnBrg1
transgenic lenses using the Database for Annotation, Visualization
and Integrated Discovery (DAVID). Upregulated genes, red;
downregulated genes, blue.
Additional file 7: Loss of function of Brg1 via lens-specific deletion
causes multiple ocular defects. Compared to the control littermates
(A) at postnatal day 21, lens-specific inactivation of Brg1 within the lens
placode derivatives leaded to microphthalmia in the mutant mice (B).
The size of the P1 microdissected eyeballs (D) from the conditional
knockout mutants was reduced, with a much smaller pupil opening
(arrows) compared to the wild-type controls (C).
Additional file 8: Analysis of the Le-Cre-driven deletion efficiency in
Brg1 cKO. (A) PCR analysis of genomic DNA prepared from newborn
lens, cornea and tail. Detection of Brg1 deletion showed occasional
germline deletion of Brg1 [52]: Lanes 1 and 2, lens; lane 3, tail; lane 4,
cornea from two Brg1flox/flox; Le-Cre mice (M1 and M2) [7]. (B) PCR
detection of Brg1flox, Brg1 WT and cre alleles. Lane 1-lens DNA from M1,
which still showed Brg1flox band; two-tailed DNA from a Brg1flox/+ mouse;
three-tailed DNA from M1 detected Cre expression. (C)
Immunofluorescence localization of Brg1 in wild-type (Brg1flox/flox) and
Brg1 cKO lenses (Brg1flox/flox; Le-Cre).
Additional file 9: Immunolocalization of aA-crystallin, g-crystallin
and Pax6 in Brg1 cKO. Nuclei were shown by 4’,6-diamidino-2-
phenylindole (DAPI) staining (blue). Perturbed aA-crystallin (a-Cry) and g-
crystallin (g-Cry) expression (red) was found in the Brg1 mutant lenses.
Pax6 (red) is mainly expressed in the lens epithelial cells in both Brg1flox/
flox and Brg1 mutant P1 lenses. Scale bar, 100 μm.
Additional file 10: A list of 230 transcripts that were commonly
deregulated in both dnBrg1 transgenic and Brg1 cKO lenses.
Upregulated genes, red; downregulated genes, blue.
Additional file 11: Identification of several GO categories “Biological
Function” using the Database for Annotation, Visualization and
Integrated Discovery (DAVID) that contain large numbers of genes
disrupted in dnBrg1 transgenic lenses. Upregulated genes, red;
downregulated genes, blue.
Additional file 12: A list of primers used in qRT-PCR.
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